Related Experiment Video
Updated: May 30, 2026

06:01
Transcranial Direct Current Stimulation for Online Gamers
Published on: November 9, 2019
Pathological gambling: a neurobiological and clinical update
Summary
The study reviews neurobiological evidence linking pathological gambling and drug addiction, supporting their proposed merger in the DSM-5. It also updates national gambling trends and available treatments.
Area of Science:
- Neurobiology
- Psychiatry
- Behavioral Science
Background:
- The upcoming DSM-5 considers merging pathological gambling with drug addictions.
- Neurobiological similarities exist between gambling disorder and substance use disorders.
- Understanding these links is crucial for accurate diagnosis and treatment.
Discussion:
- Neurobiological research indicates shared pathways, including reward system dysregulation, in both pathological gambling and drug addiction.
- Examining national gambling trends reveals increasing prevalence and evolving patterns of engagement.
- Current treatment modalities for gambling disorder are reviewed, highlighting areas for improvement.
Key Insights:
- Shared neurobiological underpinnings support the potential reclassification of gambling disorder.
- Understanding national trends is crucial for public health interventions and resource allocation.
- Evidence-based treatments are essential for addressing the growing burden of behavioral addictions.
Outlook:
- Further research into the neurobiology of addiction can refine diagnostic criteria.
- Integrating gambling disorder treatment into addiction services may improve patient outcomes.
- Policy changes informed by epidemiological data can mitigate the public health impact of gambling.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Diagnostic and Statistical Manual of Mental Disorders (DSM)
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Obsessive-Compulsive Disorder
Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

